EFCAB6: A Potential Drug Target and Biomarker for DJ-1-Binding Protein

Target Name: EFCAB6

NCBI ID: G64800

EFCAB6

EFCAB6: A Potential Drug Target and Biomarker for DJ-1-Binding Protein

Abstract:

The endocannabinoid system (ECS) plays a crucial role in maintaining various physiological functions, including mood regulation, pain perception, and neurotransmission. One of the key components of the ECS is the cannabinoid receptor, CBR1, which is involved in the therapeutic effects of cannabis . TheJournal of Neuroscience articles have reported that the drug-targeting of CBR1 has been extensively studied, and the identification of potential drug targets is an important step in the development of new treatments for various neurological disorders. In this article, we discuss the EFCAB6 protein , a potential drug target and biomarker for DJ-1-binding protein, and its implications in the field of pharmacology.

Introduction:

The endocannabinoid system (ECS) is a complex cell-signaling system that involves the synthesis, storage, and degradation of cannabinoids, which are derived from the cannabis plant. The ECS is composed of several key components, including the cannabinoid receptor, CBR1, which is responsible for the therapeutic effects of cannabis. The CBR1 receptor is activated by the psychoactive compounds in cannabis, which bind to the receptor and alter the activity of other cellular components.

One of the main challenges in the study of CBR1 is the difficulty in identifying and characterizing the full spectrum of CBR1-active compounds, as many of these compounds have diverse effects and pharmacological profiles. To overcome this challenge, researchers have used a variety of techniques , including high-throughput screening and gene expression arrays, to identify potential drug targets for CBR1. One of the promising protein targets identified by these studies is the EFCAB6 protein, a component of the CBR1 receptor complex.

EFCAB6: A Putative Drug Target

The EFCAB6 protein is a member of the superfamily of transmembrane proteins known as the EFCAM family. This family is characterized by the presence of a unique C-terminus and a characteristic conserved structure in the middle of the transmembrane region. The EFCAMs are involved in various cellular processes, including intracellular signaling, cell adhesion, and transcriptional regulation.

Recent studies have demonstrated that EFCAB6 plays a critical role in the regulation of CBR1-mediated signaling pathways. EFCAB6 is a protein that can bind to the CBR1 receptor and enhance its activity, suggesting that it may be a drug target for CBR1-mediated signaling pathways..

The EFCAB6-CBR1 interaction:

The EFCAB6 protein is involved in the regulation of CBR1-mediated signaling pathways by interacting with the CBR1 receptor. This interaction is mediated by the EFCAMs, which are involved in the regulation of intracellular signaling pathways. The EFCAMs are characterized by the presence of a unique C-terminus and a characteristic conserved structure in the middle of the transmembrane region.

The EFCAB6-CBR1 interaction is thought to occur through the EFCAMs, which provide a scaffold to the CBR1 receptor and enhance its activity. This interaction between EFCAB6 and CBR1 is critical for the regulation of CBR1-mediated signaling pathways, including the modulation of cellular behaviors , such as cell proliferation, migration, and neurotransmission.

EFCAB6 as a potential biomarker:

The EFCAB6 protein is not only a potential drug target but also a potential biomarker for CBR1-mediated signaling pathways. The EFCAB6 protein can be used as a marker for the expression of CBR1-mediated signaling pathways, as it is expressed in various tissues and cells types, including brain, spinal cord, and peripheral tissues.

The expression of EFCAB6 is also known to be regulated by CBR1, which is a known regulator of EFCAMs. The CBR1 receptor is involved in the regulation of intracellular signaling pathways, including the modulation of EFCAB6 expression. This interaction between CBR1 and

Protein Name: EF-hand Calcium Binding Domain 6

Functions: Negatively regulates the androgen receptor by recruiting histone deacetylase complex, and protein DJ-1 antagonizes this inhibition by abrogation of this complex (PubMed:12612053). Microtubule inner protein (MIP) part of the dynein-decorated doublet microtubules (DMTs) in cilia axoneme, which is required for motile cilia beating (Probable)

The "EFCAB6 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about EFCAB6 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets